Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus

被引:371
作者
Katakami, Naoto [1 ,2 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Osaka, Japan
关键词
Diabetes; Atherosclerosis; Cardiovascular disease; Oxidative stress; Advanced glycation end-products (AGEs); GLYCATION END-PRODUCTS; PROTEIN-KINASE-C; NEUTROPHIL EXTRACELLULAR TRAPS; HUMAN ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; INSULIN-RESISTANCE; HIGH GLUCOSE; CHLAMYDIA-PNEUMONIAE; DEPENDENT ACTIVATION;
D O I
10.5551/jat.RV17014
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Diabetic macroangiopathy, atherosclerosis secondary to diabetes mellitus (DM), causes cerebro-cardiovascular diseases, which are major causes of death in patients with DM and significantly reduce their quality of life. The alterations in vascular homeostasis due to endothelial and vascular smooth muscle cell dysfunction are the main features of diabetic macroangiopathy. Although multiple metabolic abnormalities that characterize diabetes are involved in the progression of atherosclerosis in patients with DM, it may be said that prolonged exposure to hyperglycemia and insulin resistance clustering with other risk factors such as obesity, arterial hypertension, and dyslipidemia play crucial roles. Laboratory and clinical researches in the past decades have revealed that major biochemical pathways involved in the development of diabetic macroangiopathy are as follows: overproduction of reactive oxygen species, increased formation of advanced glycation end-products (AGEs) and activation of the AGEs-receptor for AGE axis, polyol and hexosamine flux, protein kinase C activation, and chronic vascular inflammation. Among them, oxidative stress is considered to be a key factor.
引用
收藏
页码:27 / 39
页数:13
相关论文
共 86 条
[1]   Assessment and treatment of endothelial dysfunction in humans [J].
Anderson, TJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (03) :631-638
[2]   Redox-Sensitive Transcription Factor Nrf2 Regulates Vascular Smooth Muscle Cell Migration and Neointimal Hyperplasia [J].
Ashino, Takashi ;
Yamamoto, Masayuki ;
Yoshida, Takemi ;
Numazawa, Satoshi .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (04) :760-U273
[3]   Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[4]   Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[5]   Insulin Resistance, Hyperglycemia, and Atherosclerosis [J].
Bornfeldt, Karin E. ;
Tabas, Ira .
CELL METABOLISM, 2011, 14 (05) :575-585
[6]  
BRETT J, 1993, AM J PATHOL, V143, P1699
[7]   Neutrophil extracellular traps kill bacteria [J].
Brinkmann, V ;
Reichard, U ;
Goosmann, C ;
Fauler, B ;
Uhlemann, Y ;
Weiss, DS ;
Weinrauch, Y ;
Zychlinsky, A .
SCIENCE, 2004, 303 (5663) :1532-1535
[8]   RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice [J].
Bucciarelli, LG ;
Wendt, T ;
Qu, W ;
Lu, Y ;
Lalla, E ;
Rong, LL ;
Goova, MT ;
Moser, B ;
Kislinger, T ;
Lee, DC ;
Kashyap, Y ;
Stern, DM ;
Schmidt, AM .
CIRCULATION, 2002, 106 (22) :2827-2835
[9]   Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: A new therapeutic approach for the treatment of inflammatory diseases [J].
Chen, XL ;
Kunsch, C .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (08) :879-891
[10]  
Chiu B, 1997, CIRCULATION, V96, P2144